VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$99.9M
This Quarter Return
+13.1%
1 Year Return
+37.46%
3 Year Return
+659.14%
5 Year Return
–
10 Year Return
–
AUM
$94.1M
AUM Growth
+$94.1M
(+10%)
Cap. Flow
-$14.6M
Cap. Flow
% of AUM
-15.47%
Top 10 Holdings %
Top 10 Hldgs %
78.6%
Holding
35
New
10
Increased
3
Reduced
5
Closed
6
Top Buys
| 1 |
Heron Therapeutics
HRTX
|
$6.25M |
| 2 |
PNT
POINT Biopharma Global Inc. Common Stock
PNT
|
$3.6M |
| 3 |
Inspire Medical Systems
INSP
|
$2.52M |
| 4 |
OPTN
OptiNose
OPTN
|
$2.44M |
| 5 |
Tenet Healthcare
THC
|
$2.44M |
Top Sells
| 1 |
CFMS
Conformis, Inc. Common Stock
CFMS
|
$16.4M |
| 2 |
Immunocore
IMCR
|
$4.99M |
| 3 |
ADMA Biologics
ADMA
|
$4.92M |
| 4 |
Healthcare Services Group
HCSG
|
$3.27M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$2.84M |
Sector Composition
| 1 | Healthcare | 99.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LMDX
26
DELISTED
LumiraDx Limited Common Shares
LMDX
| $514K | 0.45% | 571,428 | – | – |
|
27
Terns Pharmaceuticals
TERN
$609M
| $108K | 0.1% | +10,646 | New | +$108K |
|
28
Assertio
ASRT
$80.4M
| – | – | -234,766 | Closed | -$533K |
|
|
29
BioCryst Pharmaceuticals
BCRX
$1.74B
| – | – | -225,000 | Closed | -$2.84M |
|
30
SPDR Euro Stoxx 50 ETF
FEZ
$4.54B
| – | – | 0 | – | – |
|
31
Glaukos
GKOS
$5.5B
| – | – | -6,896 | Closed | -$367K |
|
|
NYXH
32
Nyxoah
NYXH
$234M
| – | – | -79,021 | Closed | -$498K |
|
33
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – | 0 | – | – |
|
34
The Oncology Institute
TOI
$318M
| – | – | -548,841 | Closed | -$2.54M |
|
35
Zymeworks
ZYME
$1.12B
| – | – | -234,902 | Closed | -$1.45M |
|